Analysts Offer Predictions for Envoy Medical Q1 Earnings

Envoy Medical, Inc. (NASDAQ:COCH) – Brookline Capital Management issued their Q1 2025 EPS estimates for Envoy Medical in a note issued to investors on Wednesday, April 2nd. Brookline Capital Management analyst T. Bussian anticipates that the company will post earnings of ($0.41) per share for the quarter. The consensus estimate for Envoy Medical’s current full-year earnings is ($1.21) per share. Brookline Capital Management also issued estimates for Envoy Medical’s Q2 2025 earnings at ($0.35) EPS, Q3 2025 earnings at ($0.30) EPS, Q4 2025 earnings at ($0.30) EPS and FY2025 earnings at ($1.36) EPS.

Envoy Medical Stock Performance

Envoy Medical stock opened at $1.28 on Monday. The stock has a market cap of $25.81 million, a PE ratio of -0.90 and a beta of 2.35. The stock has a 50-day moving average of $1.44 and a two-hundred day moving average of $1.93. Envoy Medical has a one year low of $1.21 and a one year high of $7.10.

Envoy Medical (NASDAQ:COCH) last posted its quarterly earnings data on Friday, March 28th. The company reported ($0.45) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.12). The firm had revenue of $0.04 million during the quarter, compared to analysts’ expectations of $0.07 million.

Hedge Funds Weigh In On Envoy Medical

Hedge funds and other institutional investors have recently modified their holdings of the stock. DSG Capital Advisors LLC purchased a new stake in Envoy Medical during the 4th quarter worth approximately $234,000. Lake Street Advisors Group LLC acquired a new position in shares of Envoy Medical in the 4th quarter valued at $65,000. CIBC Private Wealth Group LLC purchased a new position in Envoy Medical in the 4th quarter worth $65,000. Finally, Citadel Advisors LLC acquired a new stake in Envoy Medical during the 4th quarter worth about $42,000. 8.59% of the stock is owned by hedge funds and other institutional investors.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.